Kyverna Therapeutics (KYTX) Net Equity Issued and Repurchased (2023 - 2026)
Kyverna Therapeutics' Net Equity Issued and Repurchased came in at $2.24 million for Q2 2026, up 823.5% from the prior quarter.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kyverna Therapeutics reported Net Equity Issued and Repurchased of $101.45 million; for FY2025, it came in at $98.97 million, down 71.0% from FY2024.
- Going back by year, Net Equity Issued and Repurchased was $341.17 million in FY2024 (+469.6%) and $59.9 million in FY2023.
- The five-year range for quarterly Net Equity Issued and Repurchased is $3,000 (Q1 2025) to $341.17 million (Q1 2024).
- Business Quant data shows KYTX's Net Equity Issued and Repurchased at $243,000 (Q1 2026), $97.31 million (Q4 2025) and $1.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Kyverna Therapeutics | 312.78 Mn | -573.60 Mn | - | 4.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.14 Mn |
| Mar 31, 2026 | 243,000.00 |
| Dec 31, 2025 | 116.24 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 32,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | 73,000.00 |
| Mar 31, 2024 | 341.24 Mn |
| Dec 31, 2023 | 275,000.00 |
| Sep 30, 2023 | 35.15 Mn |
| Jun 30, 2023 | 36,000.00 |
| Mar 31, 2023 | 24,000.00 |
API Access
Kyverna Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();